These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of dantrolene sodium in myotonic dystrophy. Mamoli B; Dal-Bianco P; Zeitlhofer K Eur Neurol; 1983; 22(1):29-34. PubMed ID: 6840139 [TBL] [Abstract][Full Text] [Related]
5. Spasmolytic properties of dantrolene sodium: clinical evaluation. Sheplan L; Ishmael C Mil Med; 1975 Jan; 140(1):26-9. PubMed ID: 804674 [No Abstract] [Full Text] [Related]
6. Dantrolene sodium: an effective therapeutic agent for the treatment of spasticity in children. GarcĂa-Castro JM Bol Asoc Med P R; 1977 Aug; 69(8):263-5. PubMed ID: 334191 [No Abstract] [Full Text] [Related]
7. A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Glass A; Hannah A Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209 [No Abstract] [Full Text] [Related]
9. Spasticity and the effect of dantrolene sodium. Monster AW Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132 [No Abstract] [Full Text] [Related]
10. Comparison of dantrolene sodium and diazepam in the treatment of spasticity. Schmidt RT; Lee RH; Spehlmann R J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344 [TBL] [Abstract][Full Text] [Related]
11. Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Tolosa ES; Soll RW; Loewenson RB JAMA; 1975 Sep; 233(10):1046. PubMed ID: 1099254 [No Abstract] [Full Text] [Related]
12. Dantrolene sodium: long-term effects in patients with muscle spasticity. Joynt RL Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122 [TBL] [Abstract][Full Text] [Related]
13. Dantrolene sodium: long-term effects in severe spasticity. Chyatte SB; Basmajian JV Arch Phys Med Rehabil; 1973 Jul; 54(7):311-5. PubMed ID: 4577936 [No Abstract] [Full Text] [Related]
14. [Myo-relaxant action of sodium Dantrolene in the treatment of tetanus]. Rocha H Rev Inst Med Trop Sao Paulo; 1975; 17(4):257-62. PubMed ID: 1181641 [No Abstract] [Full Text] [Related]
15. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease. Weiser R; Terenty T; Hudgson P; Weightman D Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589 [No Abstract] [Full Text] [Related]
17. [Dantrolene in the treatment of spasticity]. Korczyn AD; Galinsky D; Berginer VM; Goren C Harefuah; 1978 Jul; 95(1):10-1. PubMed ID: 359424 [No Abstract] [Full Text] [Related]
18. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam. Schmidt RT; Lee RH; Spehlmann R Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625 [No Abstract] [Full Text] [Related]
19. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)]. Gonsette RE; Capart T; Demonty L Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084 [TBL] [Abstract][Full Text] [Related]
20. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity]. Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244 [No Abstract] [Full Text] [Related] [Next] [New Search]